Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib vs Sunitinib in Imatinib-Resistant GIST
NCT01506336Phase 2Completed
- Sponsor
- AB Science
- Start
- Oct 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of masitinib in gastrointestinal stromal tumor (GIST), sponsored by AB Science. Started Oct 2008; status: completed.
02
Drugs
masitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01506336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506336.